Pim protein kinase-3 is regulated by TNF-α and promotes endothelial cell sprouting

Molecules and Cells

Volumn 32, Issue 3, 2011, Pages 235-241

  Yang, Handong ^a   Wang, Yinfang ^b   Qian, Hang ^b   Zhang, Peng ^b   Huang, Congxin ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b HUBEI UNIVERSITY OF MEDICINE   (China)

Author keywords

Angiogenesis; Endothelial cell; Pim 3; TNF

Indexed keywords

MESSENGER RNA; PIM PROTEIN KINASE 3; PROTEIN SERINE THREONINE KINASE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTICLE; CELL MIGRATION; CELL SPREADING; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

BLOTTING, WESTERN; CELL MOVEMENT; CELLS, CULTURED; COLLAGEN; DRUG COMBINATIONS; FEMALE; GENE EXPRESSION; GENE SILENCING; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LAMININ; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; NITRIC OXIDE SYNTHASE TYPE III; PROTEIN-SERINE-THREONINE KINASES; PROTEOGLYCANS; PROTO-ONCOGENE PROTEINS; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA STABILITY; RNA, MESSENGER; RNA, SMALL INTERFERING; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84855644771     PISSN: 10168478     EISSN: 02191032     Source Type: Journal    
DOI: 10.1007/s10059-011-1026-z     Document Type: Article

References (37)

1. Amaravadi, R., and Thompson, C.B. (2005). The survival kinases Akt and Pim as potential pharmacological targets. J. Clin. Invest. 115, 2618-2624. (Pubitemid 41434384)
2. Benelli, R., Lorusso, G., Albini, A., and Noonan, D.M. (2006). Cytokines and chemokines as regulators of angiogenesis in health and disease. Curr. Pharm. Des. 12, 3101-3115. (Pubitemid 44227572)
3. Bhattacharya, N., Wang, Z., Davitt, C., McKenzie, I.F., Xing, P.X., and Magnuson, N.S. (2002). Pim-1 associates with protein complexes necessary for mitosis. Chromosoma 111, 80-95. (Pubitemid 36067383)
4. Bochkov, V.N., Philippova, M., Oskolkova, O., Kadl, A., Furnkranz, A., Karabeg, E., Afonyushkin, T., Gruber, F., Breuss, J., Minchenko, A., et al. (2006). Oxidized phospholipids stimulate angiogenesis via autocrine mechanisms, implicating a novel role for lipid oxidation in the evolution of atherosclerotic lesions. Circ. Res. 99, 900-908. (Pubitemid 44556390)
5. Bradley, J.R. (2008). TNF-mediated inflammatory disease. J. Pathol. 214, 149-160. (Pubitemid 351160153)
6. Carmeliet, P. (2003). Angiogenesis in health and disease. Nat. Med. 9, 653-660. (Pubitemid 36749213)
7. Ezaki, T., Baluk, P., Thurston, G., La Barbara, A., Woo, C., and Mc-Donald, D.M. (2001). Time course of endothelial cell proliferation and microvascular remodeling in chronic inflammation. Am. J. Pathol. 158, 2043-2055. (Pubitemid 32545190)
8. Fiedler, L.R. (2009). Rac1 regulates cardiovascular development and postnatal function of endothelium. Cell Adh. Migr. 3, 143-145.
9. Frater-Schroder, M., Risau, W., Hallmann, R., Gautschi, P., and Bohlen, P. (1987). Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo. Proc. Natl. Acad. Sci. USA 84, 5277-5281. (Pubitemid 17129009)
10. Fujii, C., Nakamoto, Y., Lu, P., Tsuneyama, K., Popivanova, B.K., Kaneko, S., and Mukaida, N. (2005). Aberrant expression of serine/ threonine kinase Pim-3 in hepatocellular carcinoma development and its role in the proliferation of human hepatoma cell lines. Int. J. Cancer 114, 209-218. (Pubitemid 40194286)
11. Gao, B., Saba, T.M., and Tsan, M.F. (2002). Role of alpha(v) beta(3)-integrin in TNF-alpha-induced endothelial cell migration. Am. J. Physiol. 283, C1196-1205.
12. Gavard, J., Lambert, M., Grosheva, I., Marthiens, V., Irinopoulou, T., Riou, J.F., Bershadsky, A., and Mege, R.M. (2004). Lamellipodium extension and cadherin adhesion: Two cell responses to cadherin activation relying on distinct signalling pathways. J. Cell Sci. 117, 257-270. (Pubitemid 38128904)
13. Jian, J., Hu, Z.F., and Huang, Y. (2009). Effect of ginsenoside Rg3 on Pim-3 and Bad proteins in human pancreatic cancer cell line PANC-1. Ai zheng = Aizheng = Chin. J. Cancer 28, 461-465.
14. Kamba, T., and McDonald, D.M. (2007). Mechanisms of adverse effects of anti-VEGF therapy for cancer. Br. J. Cancer 96, 1788-1795. (Pubitemid 46912024)
15. Kociok, N., Radetzky, S., Krohne, T.U., Gavranic, C., and Joussen, A.M. (2006). Pathological but not physiological retinal neovascularization is altered in TNF-Rp55-receptor-deficient mice. Invest. Ophthalmol. Vis. Sci. 47, 5057-5065. (Pubitemid 46586413)
16. Li, Y., Schwabe, R.F., DeVries-Seimon, T., Yao, P.M., Gerbod-Giannone, M.C., Tall, A.R., Davis, R.J., Flavell, R., Brenner, D.A., and Tabas, I. (2005). Free cholesterol-loaded macrophages are an abundant source of tumor necrosis factor-alpha and interleukin-6: Model of NF-kappaB-and map kinase-dependent inflammation in advanced atherosclerosis. J. Biol. Chem. 280, 21763-21772. (Pubitemid 40827824)
17. Li, Y.Y., Popivanova, B.K., Nagai, Y., Ishikura, H., Fujii, C., and Mukaida, N. (2006). Pim-3, a proto-oncogene with serine/threonine kinase activity, is aberrantly expressed in human pancreatic cancer and phosphorylates bad to block bad-mediated apoptosis in human pancreatic cancer cell lines. Cancer Res. 66, 6741-6747. (Pubitemid 44085632)
18. Li, Y.Y., Wu, Y., Tsuneyama, K., Baba, T., and Mukaida, N. (2009). Essential contribution of Ets-1 to constitutive Pim-3 expression in human pancreatic cancer cells. Cancer Sci. 100, 396-404.
19. Luo, D., Luo, Y., He, Y., Zhang, H., Zhang, R., Li, X., Dobrucki, W.L., Sinusas, A.J., Sessa, W.C., and Min, W. (2006). Differential functions of tumor necrosis factor receptor 1 and 2 signaling in ischemia-mediated arteriogenesis and angiogenesis. Am. J. Pathol. 169, 1886-1898. (Pubitemid 351182017)
20. Mori, R., Kondo, T., Ohshima, T., Ishida, Y., and Mukaida, N. (2002). Accelerated wound healing in tumor necrosis factor receptor p55-deficient mice with reduced leukocyte infiltration. FASEB J. 16, 963-974. (Pubitemid 34753502)
21. Muraski, J.A., Rota, M., Misao, Y., Fransioli, J., Cottage, C., Gude, N., Esposito, G., Delucchi, F., Arcarese, M., Alvarez, R., et al. (2007). Pim-1 regulates cardiomyocyte survival downstream of Akt. Nat. Med. 13, 1467-1475. (Pubitemid 350224243)
22. Numasaki, M., Lotze, M.T., and Sasaki, H. (2004). Interleukin-17 augments tumor necrosis factor-alpha-induced elaboration of proangiogenic factors from fibroblasts. Immunol. Lett. 93, 39-43. (Pubitemid 38591518)
23. Pan, S., An, P., Zhang, R., He, X., Yin, G., and Min, W. (2002). Etk/Bmx as a tumor necrosis factor receptor type 2-specific kinase: Role in endothelial cell migration and angiogenesis. Mol. Cell. Biol. 22, 7512-7523.
24. Popivanova, B.K., Li, Y.Y., Zheng, H., Omura, K., Fujii, C., Tsuneyama, K., and Mukaida, N. (2007). Proto-oncogene, Pim-3 with serine/threonine kinase activity, is aberrantly expressed in human colon cancer cells and can prevent Bad-mediated apoptosis. Cancer Sci. 98, 321-328. (Pubitemid 46195601)
25. Secchiero, P., Gonelli, A., Carnevale, E., Corallini, F., Rizzardi, C., Zacchigna, S., Melato, M., and Zauli, G. (2004). Evidence for a proangiogenic activity of TNF-related apoptosis-inducing ligand. Neoplasia (New York, N.Y) 6, 364-373. (Pubitemid 38924851)
26. Tanner, J.E. (2004). Nucleosomes activate NF-kappaB in endothelial cells for induction of the proangiogenic cytokine IL-8. Int. J. Cancer 112, 155-160. (Pubitemid 39249504)
27. Thurston, G., Murphy, T.J., Baluk, P., Lindsey, J.R., and McDonald, D.M. (1998). Angiogenesis in mice with chronic airway inflammation: Strain-dependent differences. Am. J. Pathol. 153, 1099-1112. (Pubitemid 28465833)
28. Trivella, M., Pezzella, F., Pastorino, U., Harris, A.L., and Altman, D.G. (2007). Microvessel density as a prognostic factor in nonsmall-cell lung carcinoma: A meta-analysis of individual patient data. Lancet Oncol. 8, 488-499. (Pubitemid 46805904)
29. van den Berg, Y.W., van den Hengel, L.G., Myers, H.R., Ayachi, O., Jordanova, E., Ruf, W., Spek, C.A., Reitsma, P.H., Bogdanov, V.Y., and Versteeg, H.H. (2009). Alternatively spliced tissue factor induces angiogenesis through integrin ligation. Proc. Natl. Acad. Sci. USA 106, 19497-19502.
30. Wingett, D., Reeves, R., and Magnuson, N.S. (1991). Stability changes in pim-1 proto-oncogene mRNA after mitogen stimulation of normal lymphocytes. J. Immunol. 147, 3653-3659.
31. Wood, N.T., Meek, D.W., and Mackintosh, C. (2009). 14-3-3 Binding to Pim-phosphorylated Ser166 and Ser186 of human Mdm2-potential interplay with the PKB/Akt pathway and p14(ARF). FEBS Lett. 583, 615-620.
32. Wu, R.F., Xu, Y.C., Ma, Z., Nwariaku, F.E., Sarosi, G.A., Jr., and Terada, L.S. (2005). Subcellular targeting of oxidants during endothelial cell migration. J. Cell Biol. 171, 893-904. (Pubitemid 41746590)
33. Wu, Y., Wang, Y.Y., Nakamoto, Y., Li, Y.Y., Baba, T., Kaneko, S., Fujii, C., and Mukaida, N. (2010). Accelerated hepatocellular carcinoma development in mice expressing the Pim-3 transgene selectively in the liver. Oncogene 29, 2228-2237.
34. Yip-Schneider, M.T., Horie, M., and Broxmeyer, H.E. (1995). Transcriptional induction of pim-1 protein kinase gene expression by interferon gamma and posttranscriptional effects on costimulation with steel factor. Blood 85, 3494-3502.
35. Zhang, P., Wang, H., Min, X., Wang, Y., Tang, J., Cheng, J., Li, D., Chen, X., Cheng, F., Wang, N., et al. (2009). Pim-3 is expressed in endothelial cells and promotes vascular tube formation. J. Cell. Physiol. 220, 82-90.
36. Zhu, T., Sennlaub, F., Beauchamp, M.H., Fan, L., Joyal, J.S., Checchin, D., Nim, S., Lachapelle, P., Sirinyan, M., Hou, X., et al. (2006). Proangiogenic effects of protease-activated receptor 2 are tumor necrosis factor-alpha and consecutively Tie2 dependent. Arterioscler. Thromb. Vasc. Biol. 26, 744-750. (Pubitemid 43732146)
37. Zippo, A., De Robertis, A., Bardelli, M., Galvagni, F., and Oliviero, S. (2004). Identification of Flk-1 target genes in vasculogenesis: Pim-1 is required for endothelial and mural cell differentiation in vitro. Blood 103, 4536-4544. (Pubitemid 38745981)